Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jan 1;179(1):323-8.
doi: 10.1084/jem.179.1.323.

CDR3 length in antigen-specific immune receptors

Affiliations

CDR3 length in antigen-specific immune receptors

E P Rock et al. J Exp Med. .

Abstract

In both immunoglobulins (Ig) and T cell receptors (TCR), the rearrangement of V, D, and J region sequence elements during lymphocyte maturation creates an enormous degree of diversity in an area referred to as the complementarity determining region 3 (CDR3) loop. Variations in the particular V, D, and J elements used, precise points of recombination, and random nucleotide addition all lead to extensive length and sequence heterogeneity. CDR3 loops are often critical for antigen binding in Igs and appear to provide the principal peptide binding residues in TCRs. To better understand the physical and selective constraints on these sequences, we have compiled information on CDR3 size variation for Ig H, L (kappa and lambda) and TCR alpha, beta, gamma, and delta. Ig H and TCR delta CDR3s are the most variable in size and are significantly longer than L and gamma chains, respectively. In contrast, TCR alpha and beta chain distributions are highly constrained, with nearly identical average CDR3 lengths, and their length distributions are not altered by thymic selection. Perhaps most significantly, these CDR3 length profiles suggest that gamma/delta TCRs are more similar to Igs than to alpha/beta TCRs in their putative ligand binding region, and thus gamma/delta and alpha/beta T cells may have fundamentally different recognition properties.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1986 Feb;83(3):742-6 - PubMed
    1. Genomics. 1992 Aug;13(4):1209-30 - PubMed
    1. J Mol Biol. 1987 Aug 20;196(4):901-17 - PubMed
    1. Nature. 1988 Feb 18;331(6157):627-31 - PubMed
    1. Cell. 1988 Aug 12;54(4):473-84 - PubMed

Publication types

MeSH terms

Substances